Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention
Richard G. Jung, Trevor Simard, Pietro Di Santo, Shan Dhaliwal, Caleb Sypkes, Anne‐Claire Duchez, Robert B. Moreland, Katlyn Taylor, Simon Parlow, Sarah Visintini, Alisha Labinaz, Jeffrey A. Marbach, Kiran Sarathy, Jordan Bernick, Joanne Joseph, Paul Boland, Omar Abdel‐Razek, David T. Harnett, F. Daniel Ramirez, Benjamin Hibbert
Topics & Concepts
MedicinePercutaneous coronary interventionCardiologyInternal medicineCoronary angiographyRevascularizationAdverse effectPlasminogen activatorPlasminogen activator inhibitor-1Myocardial infarctionProtease and Inhibitor MechanismsBlood Coagulation and Thrombosis MechanismsAngiogenesis and VEGF in Cancer